About ProPharma Group

ProPharma Group partners with life science companies to solve their complex challenges. As an extension of your team, we care about not only the progression of your products through the development lifecycle, but also the safety of your products and the patients who use them.  Our staff has an array of expertise to expand your capacity and capabilities, and draws from their vast knowledge base to custom tailor solutions unique to your project needs.

Values AT Propharma Group

We Will, at All Times

Conduct our business with integrity

Be a company colleagues are proud to be part of

Uphold our social responsibility and respect our physical environment

Commitment to Colleagues

Provide an environment that is based on:

Mutual respect – Treat others the way you would like to be treated

Continual improvements to create a sustainable balance between personal and work life

Reward colleagues proportional to their contributions to the company’s success

Commitment to Clients

Make the best decisions for the clients’ long-term success

Reward client and partner loyalty

Our Leadership team

Dawn Sherman

President

Rob Chestnut

Chief Financial Officer

Mike Byrd

Chief Technology Officer

Gil Price, MD

Chief Medical Officer

Steve Swantek

Senior Vice President, Medical Information and Pharmacovigilance

Joe Biehl

Senior Vice President, Consulting Operations

Rachel Bias

Senior Vice President, Human Resources

Mike Burman

Vice President, Global Medical Information

Jim Kolbet, PMP

Vice President, Consulting

Derek Feagans

General Counsel

ProPharma Group Board

Richard Thomas

Company Blog

May 14, 2018
The Power to See Differences that Matter
What are the real-world consequences of giving inadequate consideration to power when developing a… Read More
April 24, 2018
ProPharma Group Announces New President / CEO
ProPharma Group announces today that Dawn Sherman will be joining the company as President… Read More
April 3, 2018
Understanding the New Combination Product PMSR Guidance Documents and Impact…
Take a closer look at new FDA guidance documents surrounding postmarketing safety reporting (PMSR)… Read More
More Articles

UPCOMING Events

June 04, 2018
BIO International
The BIO International Convention  attracts more than 16,000 biotechnology and pharma leaders who come togethe... Read More
June 05, 2018
DIA Pharmacovigilance Conference
Join the DIA Pharmacovigilance Conference to discuss the current landscape and join intense and well-lead dis... Read More
June 24, 2018
DIA Annual 2018
The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe. Designed to ... Read More
All Events
Contact Us